Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PreBebe Preterm (프리베베 프리텀) is a specialized nutritional supplement developed by LYS PHARMA specifically designed to support pregnancy health and reduce the risk of spontaneous preterm birth. It is formulated as a combination of specific probiotic strains, typically including *Lactobacillus rhamnosus* HN001 and *Lactobacillus acidophilus* La-14, alongside essential micronutrients such as Vitamin D (cholecalciferol). The supplement's primary mechanism of action involves the stabilization of the vaginal and gut microbiota to prevent dysbiosis and ascending infections, which are major contributors to premature labor. Additionally, the inclusion of Vitamin D helps modulate systemic inflammatory responses and supports immune function, further mitigating risk factors associated with preterm delivery. It is part of LYS PHARMA's broader PreBebe line of prenatal and maternal health products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PreBebe Preterm.